As previously reported [12], the alb-SREBP-1a mice developed visceral obesity, fatty liver, and dyslipidemia characterized by increased serum lipids, i.e., triglycerides (TG), but not cholesterol, indicating insulin resistance. This evidence concerns the gene ALB and Insulin resistance.